Should you buy L&T, Voltas, Dr Reddy's Labs, Titagarh Rail, other stocks today? Here's what brokerages recommend

As Dalal Street enters the January 31 session, brokerages have several stocks on their radar. Here's what Citi, HSBC, Jefferies, CLSA, Nomura, Morgan Stanley, JPMorgan, Macquarie and Goldman Sachs make of stocks such as Larsen & Toubro (L&T), Voltas, Dr Reddy's Labs, Laboratories, Titagarh Rail System:

L&T share target price

Four brokerages, CLSA, Citi, Jefferies and Goldman Sachs have maintained a 'buy' call on Larsen & Toubro (L&T) shares with a target of Rs 4,260, Rs 4,082, Rs 4135 and Rs 3,760, respectively.

Morgan Stanley has maintained an 'overweight' rating on L&T with a target of Rs 4,171.

Titagarh Rail System share target price

HSBC has maintained a 'buy' call on Titagarh Rail System with a target of Rs 1200.

Petronet LNG share target price

CLSA has a 'sell' call on Petronet LNG with a target of Rs 240.

JP Morgan has maintained an 'overweight' rating on Petronet LNG with a target of Rs 310, while Jefferies has maintained an 'overweight' rating on the stock with a target of Rs 310.

CLSA has an 'underperform' rating on  Nippon Life India Asset Management with a target of Rs 550.

Both HSBC and Jefferies have maintained a 'buy' call on Nippon Life India Asset Management shares with a target of Rs 613 and Rs 610, respectively.

KPIT Technologies share target price

Both Goldman Sachs and HSBC have a 'buy' call on KPIT Technologies shares with a target of Rs 1,850 and Rs 1,930, respectively.

JP Morgan has maintained an 'underweight' rating on KPIT Technologies with a target of Rs 1,150.

PB Fintech share target price

CLSA has maintained an 'outperform' rating on PB Fintech shares with a target of Rs 1,020. Morgan Stanley, on other side, has maintained an 'overweight' rating on the stock with a target of Rs 965. While Macquarie has maintained an 'underperform' on the PB Fintech stock with a target of Rs 610.

Citi has maintained a 'buy' call on PB Fintech with a target of Rs 1,150.

SRF share target price

Morgan Stanley has maintained an 'overweight' rating on SRF shares with a target of Rs 2,634.

Jefferies on has maintained an 'underperform' rating on SRF with a target of Rs 2,140.

Astral share target price

CLSA has maintained a 'sell' call on Astral shares with a target of Rs 1,760.

Morgan Stanley has maintained an 'equal-weight' rating on Astral with a target of Rs 1,909.

Voltas share target price

Nomura has maintained a 'buy' call on Voltas shares with a target of Rs 1,202.

Macquarie has maintained a 'neutral' rating on Voltas with a target of Rs 842.

M&M Finance share target price

CLSA has maintained a 'buy' call on Mahindra & Mahindra Finance shares with a target of Rs 360, while Jefferies has maintained a 'hold' call on the stock with a target of Rs 300.

Morgan Stanley has maintained an 'equal-weight' rating on M&M Finance with a target of Rs 300, while JP Morgan has maintained an 'underweight' rating on the stock with a target of Rs 260.

Citi has maintained a 'neutral' rating on M&M Finance with a target of Rs 315.

Dr Reddy's Labs share target price

Both CLSA and Jefferies have an 'underperform' rating on Dr Reddy's Laboratories shares with a target of Rs 6,080 and Rs 5,040, respectively. While Macquarie has maintained an 'outperform' rating on the stock with a target of Rs 6,400.

Catch the latest stock market updates here. For all other news related to business, politics, tech and auto, visit Zeebiz.com.